User profiles for Jean-Pierre Issa
 | Jean-Pierre IssaCoriell Institute for Medical Research Verified email at coriell.org Cited by 75883 |
Alterations in DNA methylation: a fundamental aspect of neoplasia
Neoplastic cells simultaneously harbor widespread genomic hypomethylation, more regional
areas of hypermethylation, and increased DNA-methyltransferase (DNA-MTase) activity. …
areas of hypermethylation, and increased DNA-methyltransferase (DNA-MTase) activity. …
CpG island methylator phenotype in cancer
JP Issa - Nature Reviews Cancer, 2004 - nature.com
DNA hypermethylation in CpG-rich promoters is now recognized as a common feature of
human neoplasia. However, the pathophysiology of hyper-methylation (why, when, where) …
human neoplasia. However, the pathophysiology of hyper-methylation (why, when, where) …
Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System
BACKGROUND. Recent studies have highlighted issues with the International Prognostic
Scoring System (IPSS) model in relation to the exclusion of many subgroups that now …
Scoring System (IPSS) model in relation to the exclusion of many subgroups that now …
[PDF][PDF] Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells
Reversal of promoter DNA hypermethylation and associated gene silencing is an attractive
cancer therapy approach. The DNA methylation inhibitors decitabine and azacitidine are …
cancer therapy approach. The DNA methylation inhibitors decitabine and azacitidine are …
Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation
Purpose: The PTEN gene at chromosome 10q23.3 is a tumor-suppressor genethat is inactivated
in several types of human tumors. Althoughmutation and homozygous deletion are the …
in several types of human tumors. Althoughmutation and homozygous deletion are the …
Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells
Breast cancer is the most common malignancy in women and hormone resistance is a
challenging problem in its treatment. Loss of estrogen receptor expression is an important means …
challenging problem in its treatment. Loss of estrogen receptor expression is an important means …
Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications
V Santini, HM Kantarjian, JP Issa - Annals of internal medicine, 2001 - acpjournals.org
Methylation of DNA is a biochemical modification that can influence gene expression and is
involved in inactivating one of the two X chromosomes in women. Evidence that has …
involved in inactivating one of the two X chromosomes in women. Evidence that has …
Phase 1/2 study of the combination of 5-aza-2′-deoxycytidine with valproic acid in patients with leukemia
…, C Bueso-Ramos, J Fiorentino, E Jabbour, JP Issa - Blood, 2006 - ashpublications.org
We conducted a phase 1/2 study of the combination of 5-aza-2′-deoxycytidine (decitabine)
and the histone deacetylase inhibitor valproic acid (VPA) in patients with advanced …
and the histone deacetylase inhibitor valproic acid (VPA) in patients with advanced …
p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3
For several human tumour types, allelic toss data suggest that one or more tumour suppressor
genes reside telomeric to the p53 gene at chromosome 17p13.1. In the present study we …
genes reside telomeric to the p53 gene at chromosome 17p13.1. In the present study we …
Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer
Purpose Overexpression of epidermal growth factor receptor (EGFR) is common in head and
neck squamous cell carcinoma (HNSCC). Recent studies showed that EGFR inhibitors are …
neck squamous cell carcinoma (HNSCC). Recent studies showed that EGFR inhibitors are …